Staatscourant van het Koninkrijk der Nederlanden
Datum publicatie | Organisatie | Jaargang en nummer | Rubriek | Datum ondertekening |
---|---|---|---|---|
Ministerie van Volksgezondheid, Welzijn en Sport | Staatscourant 2015, 3543 | Besluiten van algemene strekking |
Zoals vergunningen, bouwplannen en lokale regelgeving.
Adressen en contactpersonen van overheidsorganisaties.
U bent hier:
Datum publicatie | Organisatie | Jaargang en nummer | Rubriek | Datum ondertekening |
---|---|---|---|---|
Ministerie van Volksgezondheid, Welzijn en Sport | Staatscourant 2015, 3543 | Besluiten van algemene strekking |
De Minister van Volksgezondheid, Welzijn en Sport,
Gelet op artikel 2.8 van het Besluit zorgverzekering;
Besluit:
De Regeling zorgverzekering wordt gewijzigd als volgt:
A
Bijlage 1 wordt gewijzigd als volgt:
1. In onderdeel A worden de volgende regels opgenomen:
1A06ACAO V |
116417//9259 |
NORMACOL GRANULAAT 620MG/G SACHET 10G |
1,33 |
STUK |
0,30943 |
0A09AAAO V |
116318//33166 |
CREON XTRA FORTE CAPSULE MSR (PANCREATINE 400MG) |
1,50 |
STUK |
1,61274 |
0A11CCBO V |
114888//109397 |
D-CURA DRANK 25000IE AMPUL 1ML |
0,03 |
ML |
4,68750 |
0B01ABAP V |
116162//12787 |
FRAGMIN 2500 INJVLST 12.500IE/ML WWSP 0,2ML |
0,20 |
ML |
8,89410 |
0B01ABAP V |
116161//12788 |
FRAGMIN 5000 INJVLST 25.000IE/ML WWSP 0,2ML |
0,10 |
ML |
17,78820 |
0B01ABAP V |
116251//12788 |
FRAGMIN 5000 INJVLST 25.000IE/ML WWSP 0,2ML |
0,10 |
ML |
17,78820 |
0B01ABAP V |
116432//11876 |
FRAXIPARINE INJVLST 9500IE/ML WWSP 0,3ML |
0,30 |
ML |
5,92940 |
0B01ABAP V |
116460//15963 |
FRAXIPARINE INJVLST 9500IE/ML WWSP 0,4ML |
0,30 |
ML |
5,92940 |
0B01ABAP V |
116459//11877 |
FRAXIPARINE INJVLST 9500IE/ML WWSP 0,6ML |
0,30 |
ML |
5,92940 |
0B01ABAP V |
116461//15965 |
FRAXIPARINE INJVLST 9500IE/ML WWSP 0,8ML |
0,30 |
ML |
5,92940 |
0B01ABAP V |
116433//11878 |
FRAXIPARINE INJVLST 9500IE/ML WWSP 1ML |
0,30 |
ML |
5,92940 |
0B01ABAP V |
116372//23794 |
FRAXODI INJVLST 19000 IE/ML WWSP 0,6ML |
0,15 |
ML |
11,85880 |
0C03DABO V |
115712 |
EPLERENON MYLAN TABLET FILMOMHULD 25MG |
2,00 |
STUK |
1,32000 |
0C03DABO V |
115714 |
EPLERENON MYLAN TABLET FILMOMHULD 50MG |
1,00 |
STUK |
2,20000 |
0C07ABAO V |
102513 |
NEBIVOLOL TEVA TABLET 5MG |
1,00 |
STUK |
0,40613 |
0C09CAAO V |
101864 |
IRBESARTAN SANDOZ TABLET FILMOMHULD 75MG |
2,00 |
STUK |
0,44652 |
YC09BBBO V |
107806 |
PERINDOPRIL TERT-BUTYL/AMLODIPINE SDZ TAB 4/ 5MG |
1,00 |
STUK |
1,23858 |
YC09BBBO V |
107807 |
PERINDOPRIL TERT-BUTYL/AMLODIPINE SDZ TAB 4/10MG |
1,00 |
STUK |
1,89309 |
YC09BBBO V |
107808 |
PERINDOPRIL TERT-BUTYL/AMLODIPINE SDZ TAB 8/ 5MG |
1,00 |
STUK |
1,82266 |
YC09BBBO V |
107809 |
PERINDOPRIL TERT-BUTYL/AMLODIPINE SDZ TAB 8/10MG |
1,00 |
STUK |
2,47716 |
0C10AAAO V |
116416//30823 |
CRESTOR TABLET FILMOMHULD 5MG |
2,00 |
STUK |
0,83042 |
YC10AXAO V |
114373 |
ATOZET TABLET 10/10MG |
1,00 |
STUK |
2,41302 |
YC10AXAO V |
114374 |
ATOZET TABLET 10/20MG |
1,00 |
STUK |
3,10504 |
YC10AXAO V |
114375 |
ATOZET TABLET 10/40MG |
1,00 |
STUK |
4,48907 |
0D07ADADL V |
116398//33440 |
CLOBEX SHAMPOO 0,5MG/G |
1,00 |
GRAM |
0,18635 |
1G01AFBV V |
115193//15814 |
GYNOMYK VAGINAALCREME 20MG/G +3 APPLICATORS |
15,00 |
GRAM |
0,70759 |
YG04CAAO V |
116230//104130 |
COMBODART CAPSULE 0,5/0,4MG |
1,00 |
STUK |
2,08572 |
YG04CAAO V |
116332//104130 |
COMBODART CAPSULE 0,5/0,4MG |
1,00 |
STUK |
2,08572 |
0H01BAAO V |
116352//30856 |
MINRIN MELT LYOPHILISAAT 120MCG |
1,50 |
STUK |
2,10597 |
0H01BAAO V |
115957//30857 |
MINRIN MELT LYOPHILISAAT 240MCG |
0,75 |
STUK |
4,21194 |
0J01CAAO V |
14459 |
AMOXICILLINE PCH CAPSULE 500MG |
2,25 |
STUK |
0,41542 |
0J01FAAP V |
115540//1800 |
ERYTHROCINE IV INFUSIEPOEDER FLACON 1000MG |
1,00 |
STUK |
13,61340 |
0J01GBAII V |
116198//33841 |
BRAMITOB VERNEVELOPLOSSING 75MG/ML AMPUL 4ML |
4,00 |
ML |
11,27360 |
0L01BACP V |
116331//100943 |
METOJECT INJVLST 20MG/0,4ML (50MG/ML) WWSP |
0,05 |
ML |
62,96000 |
0L04AABO V |
116406//30203 |
MYFORTIC TABLET MSR 360MG |
4,00 |
STUK |
2,95562 |
0L04AADO V |
116345//18108 |
PROGRAFT CAPSULE 5MG |
1,00 |
STUK |
14,24625 |
0M03BXAO V |
114094//12983 |
SIRDALUD MR CAPSULE MGA 6MG |
2,00 |
STUK |
0,36643 |
0N02CCAO V |
111429 |
ALMOTRIPTAN SANDOZ TABLET FILMOMHULD 12,5MG |
1,00 |
STUK |
6,21227 |
0N02CCBO V |
115968//19469 |
IMIGRAN NEUSSPRAY 10MG |
2,00 |
STUK |
6,26081 |
0N03AFBO V |
112780 |
OXCARBAZEPINE JUBILANT TABLET FILMOMHULD 300MG |
3,33 |
STUK |
0,29201 |
0N03AXCO V |
EU/1/04/279/003 |
LYRICA CAPSULE 25MG |
12,00 |
STUK |
0,45741 |
1N05ADAPD V |
116163//10194 |
IMPROMEN DECANOAS INJVLST 50MG/ML AMPUL 1ML |
0,07 |
STUK |
10,84955 |
1N05AFAPD V |
115966//7288 |
CISORDINOL DEPOT INJVLST 200MG/ML AMPUL 1ML (IM) |
0,08 |
STUK |
9,54760 |
2N05AFAO V |
115963//4299 |
TRUXAL TABLET OMHULD 50MG |
6,00 |
STUK |
0,09152 |
0N06BAAO V |
116211//31496 |
STRATTERA CAPSULE 25MG |
3,20 |
STUK |
0,11359 |
0R01ADAN V |
116353//23837 |
RHINOCORT NEVEL NEUSSPRAY 32MCG/DO 120DO |
6,25 |
DO |
0,07684 |
YR01ADAN V |
114215 |
DYMISTA NEUSSPRAY 137/50MCG/DO FLACON 120DO |
1,00 |
DO |
0,17688 |
0R03ACCIDAV |
116397//33735 |
SEREVENT AEROSOL 25MCG/DO CFKVR SPBS 120DO + INH |
4,00 |
DO |
0,23086 |
0R03BBCID V |
EU/1/12/788/001 |
SEEBRI BREEZHALER INHALPDR 44MCG MET BREEZHALER |
1,00 |
DO |
1,49000 |
YR03AKAIDCV |
EU/1/14/920/001 |
DUORESP SPIROMAX 160 UG/4,5 UG INHALATIEPOEDER |
1,00 |
DO |
0,48321 |
YR03AKAIDCV |
EU/1/14/920/004 |
DUORESP SPIROMAX 320 UG/9 UG INHALATIEPOEDER |
1,00 |
DO |
0,96642 |
YR03AKAIDCV |
116427//25887 |
SYMBICORT TURBUHALER INHALPDR 200/6MCG/DO 120DO |
1,00 |
DO |
0,48321 |
YR03ALAIDCV |
EU/1/13/862/001 |
ULTIBRO BREEZHALER INHALPDR 85/43MCG MET BREEZHAL |
1,00 |
STUK |
2,38483 |
0V03AEAO V |
112708 |
SEVELAMEERCARBONAAT TEVA 800 MG, FO TABLET |
8,00 |
STUK |
1,11700 |
2. In onderdeel A worden de volgende regels vervangen door de daarbij vermelde teksten:
‘0A10ABAPD V |
EU/1/02/230/008 |
ACTRAPID NOVOLET INJ 100IE/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABAPD V |
EU/1/02/230/008 |
ACTRAPID NOVOLET INJ 100IE/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABAPD V |
EU/1/97/030/142 |
INSUMAN RAPID SOLOSTAR INJ 100IE/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABAPD V |
EU/1/97/030/142 |
INSUMAN RAPID SOLOSTAR INJ 100IE/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABBPD V |
EU/1/04/285/016 |
APIDRA OPTISET INJ 100E/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABBPD V |
EU/1/04/285/016 |
APIDRA OPTISET INJ 100E/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABBPD V |
EU/1/04/285/032 |
APIDRA SOLOSTAR INJ 100E/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABBPD V |
EU/1/04/285/032 |
APIDRA SOLOSTAR INJ 100E/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABBPD V |
EU/1/96/007/031 |
HUMALOG KWIKPEN INJVLST 100E/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABBPD V |
EU/1/96/007/031 |
HUMALOG KWIKPEN INJVLST 100E/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABBPD V |
EU/1/99/119/009 |
NOVORAPID FLEXPEN INJVLST 100E/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABBPD V |
EU/1/99/119/009 |
NOVORAPID FLEXPEN INJVLST 100E/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABBPD V |
EU/1/99/119/010 |
NOVORAPID FLEXPEN INJVLST 100E/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABBPD V |
EU/1/99/119/010 |
NOVORAPID FLEXPEN INJVLST 100E/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ABBPD V |
EU/1/99/119/005 |
NOVORAPID NOVOLET INJVLST 100E/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ABBPD V |
EU/1/99/119/005 |
NOVORAPID NOVOLET INJVLST 100E/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ACAPD V |
EU/1/02/233/014 |
INSULATARD FLEXPEN INJ 100IE/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ACAPD V |
EU/1/02/233/014 |
INSULATARD FLEXPEN INJ 100IE/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ACAPD V |
EU/1/02/233/008 |
INSULATARD NOVOLET INJ 100IE/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ACAPD V |
EU/1/02/233/008 |
INSULATARD NOVOLET INJ 100IE/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10ACAPD V |
EU/1/97/030/148 |
INSUMAN BASAL SOLOSTAR INJ 100IE/ML WWSP 3ML |
0,40 |
ML |
2,48974’: |
0A10ACAPD V |
EU/1/97/030/148 |
INSUMAN BASAL SOLOSTAR INJ 100IE/ML PEN 3ML |
0,40 |
ML |
2,48974; |
‘0A10AEAPD V |
EU/1/00/134/010 |
LANTUS OPTISET INJ 100E/ML WWSP 3ML |
0,40 |
ML |
3,92133’: |
0A10AEAPD V |
EU/1/00/134/010 |
LANTUS OPTISET INJ 100E/ML PEN 3ML |
0,40 |
ML |
3,92133; |
‘0A10AEAPD V |
EU/1/00/134/033 |
LANTUS SOLOSTAR INJ 100E/ML WWSP 3ML |
0,40 |
ML |
3,92133’: |
0A10AEAPD V |
EU/1/00/134/033 |
LANTUS SOLOSTAR INJ 100E/ML PEN 3ML |
0,40 |
ML |
3,92133; |
‘YA10ABAPD V |
EU/1/96/007/033 |
HUMALOG MIX 25 KWIKPEN INJSUSP 100E/ML WWSP 3ML |
1,00 |
ML |
2,48974’: |
YA10ABAPD V |
EU/1/96/007/033 |
HUMALOG MIX 25 KWIKPEN INJSUSP 100E/ML PEN 3ML |
1,00 |
ML |
2,48974; |
‘YA10ABBPD V |
EU/1/96/007/035 |
HUMALOG MIX 50 KWIKPEN INJSUSP 100E/ML WWSP 3ML |
1,00 |
ML |
2,48974’: |
YA10ABBPD V |
EU/1/96/007/035 |
HUMALOG MIX 50 KWIKPEN INJSUSP 100E/ML PEN 3ML |
1,00 |
ML |
2,48974; |
‘YA10ADDPD V |
EU/1/97/030/160 |
INSUMAN COMB 25 SOLOSTAR INJ 100IE/ML WWSP 3ML |
1,00 |
ML |
2,48974’: |
YA10ADDPD V |
EU/1/97/030/160 |
INSUMAN COMB 25 SOLOSTAR INJ 100IE/ML PEN 3ML |
1,00 |
ML |
2,48974; |
‘YA10ADEPD V |
EU/1/02/229/024 |
ACTRAPHANE 30 NOVOLET INJSUSP 100IE/ML WWSP 3ML |
1,00 |
ML |
2,48974’: |
YA10ADEPD V |
EU/1/02/229/024 |
ACTRAPHANE 30 NOVOLET INJSUSP 100IE/ML PEN 3ML |
1,00 |
ML |
2,48974; |
‘0C01CAAP K |
111729//32726 |
EPIPEN JUNIOR INJVLST 0,5MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP K |
111729//32726 |
EPIPEN JUNIOR INJVLST 0,5MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP K |
114983//32726 |
EPIPEN JUNIOR INJVLST 0,5MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP K |
114983//32726 |
EPIPEN JUNIOR INJVLST 0,5MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP K |
32726 |
EPIPEN JUNIOR INJVLST 0,5MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP K |
32726 |
EPIPEN JUNIOR INJVLST 0,5MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP V |
111212//31435 |
ANAPEN 300 INJVLST 1MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP V |
111212//31435 |
ANAPEN 300 INJVLST 1MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP V |
112030//31435 |
ANAPEN 300 INJVLST 1MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP V |
112030//31435 |
ANAPEN 300 INJVLST 1MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP V |
105054//32727 |
EPIPEN INJVLST 1MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP V |
105054//32727 |
EPIPEN INJVLST 1MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP V |
114815//32727 |
EPIPEN INJVLST 1MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP V |
114815//32727 |
EPIPEN INJVLST 1MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP V |
114972//32727 |
EPIPEN INJVLST 1MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP V |
114972//32727 |
EPIPEN INJVLST 1MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘0C01CAAP V |
32727 |
EPIPEN INJVLST 1MG/ML WWSP 0,3ML |
1,00 |
ML |
148,23500’: |
0C01CAAP V |
32727 |
EPIPEN INJVLST 1MG/ML PEN 0,3ML |
1,00 |
ML |
148,23500; |
‘1C01DAAO V |
31573//17465 |
DEPONIT T 10 PLEISTER TRANSDERMAAL 37,4MG |
0,50 |
STUK |
1,08907’: |
1C01DAAO V |
31573//17465 |
DEPONIT T 10 PLEISTER TRANSDERMAAL 10MG/24UUR |
0,50 |
STUK |
1,08907; |
‘1C01DAAO V |
113636//9672 |
TRANSIDERM NITRO 5 PLEISTER MGA 25MG |
1,00 |
STUK |
0,54454’: |
1C01DAAO V |
113636//9672 |
TRANSIDERM NITRO PLEISTER 5MG/24UUR |
1,00 |
STUK |
0,54454; |
‘1C01DAAO V |
113638//9673 |
TRANSIDERM NITRO 10 PLEISTER MGA 50MG |
0,50 |
STUK |
1,08907’: |
1C01DAAO V |
113638//9673 |
TRANSIDERM NITRO PLEISTER 10MG/24UUR |
0,50 |
STUK |
1,08907; |
‘0G03CAAO V |
21841=19582 |
ESTRADIOL MYLAN 100 PLEISTER TRANSDERMAAL 8MG |
0,14 |
STUK |
1,30973’: |
0G03CAAO V |
21841=19582 |
ESTRADIOL MYLAN PLEISTER TRANSDERMAAL 100MCG/24UUR |
0,14 |
STUK |
1,30973; |
‘0G04BDBO V |
EU/1/03/270/001 |
KENTERA PLEISTER TRANSDERMAAL 36MG |
0,29 |
STUK |
2,90435’: |
0G04BDBO V |
EU/1/03/270/001 |
KENTERA PLEISTER TRANSDERMAAL 3,9MG/24UUR |
0,29 |
STUK |
2,90435; |
‘0H01CBBP V |
112909 |
SIROCTID 0,05 MG/ML OPL V INJ IN VV SPUIT |
14,00 |
ML |
8,68027’: |
0H01CBBP V |
112909 |
SIROCTID INJVLST 0,05MG/ML WWSP 1ML |
14,00 |
ML |
8,68027; |
‘0H01CBBP V |
112910 |
SIROCTID 0,1 MG/ML OPL V INJ IN VV SPUIT |
7,00 |
ML |
10,85034’: |
0H01CBBP V |
112910 |
SIROCTID INJVLST 0,1MG/ML WWSP 1ML |
7,00 |
ML |
10,85034; |
‘0H01CBBP V |
112911 |
SIROCTID 0,5 MG/ML OPL V INJ IN VV SPUIT |
1,40 |
ML |
54,25170’: |
0H01CBBP V |
112911 |
SIROCTID INJVLST 0,5MG/ML WWSP 1ML |
1,40 |
ML |
54,25170; |
‘0N02AAAO V |
110730 |
PALEXIA RETARD 200 MG TABLETTEN VERLENGDE AFGIFTE |
2,00 |
STUK |
1,04017’: |
0N02AAAO V |
110730 |
PALEXIA RETARD TABLET MVA 200MG |
2,00 |
STUK |
1,04017; |
‘YR03ALBIDCV |
EU/1/14/964/001 |
DUAKLIR GENUAIR 340 MCG/12 MCG INHALATIEPOEDER |
1,00 |
DO |
1,35511’: |
YR03ALBIDCV |
EU/1/14/964/001 |
DUAKLIR GENUAIR INHPDR 340/12MCG 60DO |
1,00 |
DO |
1,35511 |
3. In onderdeel B worden de volgende regels opgenomen:
116257//25702 |
COSMOFER INJVLST 50MG/ML AMPUL 2ML |
111314 |
EFAVIRENZ SANDOZ TABLET FILMOMHULD 600MG |
116375//1364 |
LANOXIN INJVLST 0,25MG/ML AMPUL 2ML |
116160//16734 |
PULMOZYME VERNEVELVLOEISTOF 1000E/ML AMPUL 2,5ML |
EU/1/13/886/003 |
RELVAR ELLIPTA INHPDR 92/22MCG 30DO |
EU/1/14/967/001 |
REZOLSTA TABLET FILMOMHULD 800/150MG |
4. In onderdeel B worden de volgende regels vervangen door de daarbij vermelde teksten:
‘EU/1/00/142/009 |
NOVOMIX 30 FLEXPEN INJ 100E/ML WWSP 3ML’: |
EU/1/00/142/009 |
NOVOMIX 30 FLEXPEN INJ 100E/ML PEN 3ML; |
‘EU/1/00/142/010 |
NOVOMIX 30 FLEXPEN INJ 100E/ML WWSP 3ML’: |
EU/1/00/142/010 |
NOVOMIX 30 FLEXPEN INJ 100E/ML PEN 3ML; |
‘EU/1/00/142/015 |
NOVOMIX 50 FLEXPEN INJ 100E/ML WWSP 3ML’: |
EU/1/00/142/015 |
NOVOMIX 50 FLEXPEN INJ 100E/ML PEN 3ML; |
‘EU/1/00/142/021 |
NOVOMIX 70 FLEXPEN INJ 100E/ML WWSP 3ML’: |
EU/1/00/142/021 |
NOVOMIX 70 FLEXPEN INJ 100E/ML PEN 3ML |
Deze regeling treedt in werking met ingang van 1 februari 2015. Indien de Staatscourant waarin deze regeling wordt geplaatst, wordt uitgegeven na 31 januari 2015, treedt zij in werking met ingang van de dag na de datum van uitgifte van de Staatscourant waarin zij wordt geplaatst en werkt terug tot en met 1 februari 2015.
Kopieer de link naar uw clipboard
https://zoek.officielebekendmakingen.nl/stcrt-2015-3543.html
De hier aangeboden pdf-bestanden van het Staatsblad, Staatscourant, Tractatenblad, provinciaal blad, gemeenteblad, waterschapsblad en blad gemeenschappelijke regeling vormen de formele bekendmakingen in de zin van de Bekendmakingswet en de Rijkswet goedkeuring en bekendmaking verdragen voor zover ze na 1 juli 2009 zijn uitgegeven. Voor pdf-publicaties van vóór deze datum geldt dat alleen de in papieren vorm uitgegeven bladen formele status hebben; de hier aangeboden elektronische versies daarvan worden bij wijze van service aangeboden.